Patents by Inventor Bryan Chan

Bryan Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12473301
    Abstract: 3-Carbonylaminoisoquinoline compounds of formula (I): variations thereof, and their use as inhibitors of HPK1 (hematopoietic kinase 1) are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the 3-carbonylaminoisoquinoline compounds.
    Type: Grant
    Filed: April 1, 2021
    Date of Patent: November 18, 2025
    Assignee: Genentech, Inc.
    Inventors: Jun Liang, Rohan V. Mendonca, Michael Siu, John Tellis, Weiru Wang, BinQing Wei, Bryan Chan, Edna F. Choo, Joy Drobnick, Lewis J. Gazzard, Timothy Heffron
  • Patent number: 11944606
    Abstract: Azaindole compounds and their use as inhibitors of HPK1 are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the azaindole compounds.
    Type: Grant
    Filed: February 17, 2021
    Date of Patent: April 2, 2024
    Assignee: Genentech, Inc.
    Inventors: Timothy Heffron, Sushant Malhotra, BinQing Wei, Bryan Chan, Lewis Gazzard, Emanuela Gancia, Michael Lainchbury, Andrew Madin, Eileen Seward, Yonghan Hu
  • Patent number: 11612606
    Abstract: 3-Carbonylamino-8-aminoisoquinoline compounds of formula (I): variations thereof, and their use as inhibitors of HPK1 (hematopoietic kinase 1) are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the 3-carbonylamino-8-aminoisoquinoline compounds.
    Type: Grant
    Filed: October 3, 2019
    Date of Patent: March 28, 2023
    Assignee: Genentech, Inc.
    Inventors: Jun Liang, Rohan V. Mendonca, Michael Siu, John Tellis, Weiru Wang, BinQing Wei, Bryan Chan, Edna F. Choo, Joy Drobnick, Lewis J. Gazzard, Timothy Heffron
  • Patent number: 11615474
    Abstract: Methods and system are described for optimizing data processing in cloud-based, machine learning environments. For example, through the use of a machine learning model utilizing a self organizing map and/or the use of specific processing nodes in a computer system to perform specific tasks the methods and system may more efficiently distribute tasks through a cloud computing environment and increase overall processing speeds despite increasing amounts of data. The methods and system described herein are particularly related to collateral allocation computer systems that automate the management of numerous collateral assets. For example, as the amount of collateral assets and the complexity of given transactions grow, typical allocation systems face frequent processing delays related to collateral allocations (e.g., allocations of collateral associated with Tri-Party Repos).
    Type: Grant
    Filed: May 13, 2021
    Date of Patent: March 28, 2023
    Assignee: THE BANK OF NEW YORK MELLON
    Inventors: Brian Blank, Song He, Madhusudan Rana, Pavithran Rajendran, Bryan Chan
  • Patent number: 11566003
    Abstract: Isoquinoline compounds and their use as inhibitors of HPK1 (hematopoietic kinase 1) are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the isoquinoline compounds.
    Type: Grant
    Filed: July 6, 2020
    Date of Patent: January 31, 2023
    Assignee: Genentech, Inc.
    Inventors: Bryan Chan, Joy Drobnick, Lewis Gazzard, Timothy Heffron, Jun Liang, Sushant Malhotra, Rohan Mendonca, Naomi Rajapaksa, Craig Stivala, John Tellis, Weiru Wang, BinQing Wei, Aihe Zhou, Matthew W. Cartwright, Michael Lainchbury, Emanuela Gancia, Eileen Seward, Andrew Madin, David Favor, Kin Chiu Fong, Yonghan Hu, Andrew Good
  • Publication number: 20210332064
    Abstract: 3-Carbonylaminoisoquinoline compounds of formula (I): variations thereof, and their use as inhibitors of HPK1 (hematopoietic kinase 1) are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the 3-carbonylaminoisoquinoline compounds.
    Type: Application
    Filed: April 1, 2021
    Publication date: October 28, 2021
    Applicant: Genentech, Inc.
    Inventors: Jun Liang, Rohan V. Mendonca, Michael Siu, John Tellis, Weiru Wang, BinQing Wei, Bryan Chan, Edna F. Choo, Joy Drobnick, Lewis J. Gazzard, Timothy Heffron
  • Publication number: 20210299110
    Abstract: Azaindole compounds and their use as inhibitors of HPK1 are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the azaindole compounds.
    Type: Application
    Filed: February 17, 2021
    Publication date: September 30, 2021
    Applicant: Genentech, Inc.
    Inventors: Timothy HEFFRON, Sushant MALHOTRA, BinQing WEI, Bryan CHAN, Lewis GAZZARD, Emanuela GANCIA, Michael LAINCHBURY, Andrew MADIN, Eileen SEWARD, Yonghan HU
  • Publication number: 20210264522
    Abstract: Methods and system are described for optimizing data processing in cloud-based, machine learning environments. For example, through the use of a machine learning model utilizing a self organizing map and/or the use of specific processing nodes in a computer system to perform specific tasks the methods and system may more efficiently distribute tasks through a cloud computing environment and increase overall processing speeds despite increasing amounts of data. The methods and system described herein are particularly related to collateral allocation computer systems that automate the management of numerous collateral assets. For example, as the amount of collateral assets and the complexity of given transactions grow, typical allocation systems face frequent processing delays related to collateral allocations (e.g., allocations of collateral associated with Tri-Party Repos).
    Type: Application
    Filed: May 13, 2021
    Publication date: August 26, 2021
    Inventors: Brian BLANK, Song HE, Madhusudan RANA, Pavithran RAJENDRAN, Bryan CHAN
  • Patent number: 11074653
    Abstract: Methods and system are described for optimizing data processing in cloud-based, machine learning environments. For example, through the use of a machine learning model utilizing a self organizing map and/or the use of specific processing nodes in a computer system to perform specific tasks the methods and system may more efficiently distribute tasks through a cloud computing environment and increase overall processing speeds despite increasing amounts of data. The methods and system described herein are particularly related to collateral allocation computer systems that automate the management of numerous collateral assets. For example, as the amount of collateral assets and the complexity of given transactions grow, typical allocation systems face frequent processing delays related to collateral allocations (e.g., allocations of collateral associated with Tri-Party Repos).
    Type: Grant
    Filed: June 15, 2020
    Date of Patent: July 27, 2021
    Assignee: The Bank of New York Mellon
    Inventors: Brian Blank, Song He, Madhusudan Rana, Pavithran Rajendran, Bryan Chan
  • Patent number: 11049463
    Abstract: The present invention is directed to driving waveforms and a driving method for an electrophoretic display. The method and waveforms have the advantage that the changes in the driving voltages due to the shift are minimized. In addition, the overall driving time for the waveforms is also shortened due to the shortened driving frames. There are no additional data points required as the number of the driving frames remains the same. Therefore, the power consumption is nearly identical with the waveform having driving frames of a fixed frame time.
    Type: Grant
    Filed: January 11, 2011
    Date of Patent: June 29, 2021
    Assignee: E INK CALIFORNIA, LLC
    Inventors: Craig Lin, Bryan Chan
  • Patent number: 11034692
    Abstract: Naphthyridine compounds and their use as inhibitors of HPK1 are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the naphthyridine compounds.
    Type: Grant
    Filed: August 15, 2019
    Date of Patent: June 15, 2021
    Assignee: Genentech, Inc.
    Inventors: Bryan Chan, Blake Daniels, Joy Drobnick, Lewis Gazzard, Timothy Heffron, Malcolm Huestis, Jun Liang, Sushant Malhotra, Rohan Mendonca, Naomi Rajapaksa, Michael Siu, Craig Stivala, John Tellis, Weiru Wang, BinQing Wei, Aihe Zhou, Matthew W. Cartwright, Emanuela Gancia, Graham Jones, Michael Lainchbury, Andrew Madin, Eileen Seward, David Favor, Kin Chiu Fong, Andrew Good, Yonghan Hu, Baihua Hu, Aijun Lu
  • Publication number: 20210163417
    Abstract: Isoquinoline compounds and their use as inhibitors of HPK1 (hematopoietic kinase 1) are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the isoquinoline compounds.
    Type: Application
    Filed: July 6, 2020
    Publication date: June 3, 2021
    Applicant: Genentech, Inc.
    Inventors: Bryan Chan, Joy Drobnick, Lewis Gazzard, Timothy Heffron, Jun Liang, Sushant Malhotra, Rohan Mendonca, Naomi Rajapaksa, Craig Stivala, John Tellis, Weiru Wang, BinQing Wei, Aihe Zhou, Matthew W. Cartwright, Michael Lainchbury, Emanuela Gancia, Eileen Seward, Andrew Madin, David Favor, Kin Chiu Fong, Yonghan Hu, Andrew Good
  • Patent number: 10952995
    Abstract: Azaindole compounds and their use as inhibitors of HPK1 are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the azaindole compounds.
    Type: Grant
    Filed: September 12, 2019
    Date of Patent: March 23, 2021
    Assignee: Genentech, Inc.
    Inventors: Timothy Heffron, Sushant Malhotra, BinQing Wei, Bryan Chan, Lewis Gazzard, Emanuela Gancia, Michael Lainchbury, Andrew Madin, Eileen Seward, Yonghan Hu
  • Publication number: 20200311819
    Abstract: Methods and system are described for optimizing data processing in cloud-based, machine learning environments. For example, through the use of a machine learning model utilizing a self organizing map and/or the use of specific processing nodes in a computer system to perform specific tasks the methods and system may more efficiently distribute tasks through a cloud computing environment and increase overall processing speeds despite increasing amounts of data. The methods and system described herein are particularly related to collateral allocation computer systems that automate the management of numerous collateral assets. For example, as the amount of collateral assets and the complexity of given transactions grow, typical allocation systems face frequent processing delays related to collateral allocations (e.g., allocations of collateral associated with Tri-Party Repos).
    Type: Application
    Filed: June 15, 2020
    Publication date: October 1, 2020
    Inventors: Brian BLANK, Song HE, Madhusudan RANA, Pavithran RAJENDRAN, Bryan CHAN
  • Publication number: 20200233882
    Abstract: In some examples, a controller comprises a bucketization logic to receive a bucketization indication from a host processor, and in response to the bucketization indication, partition data stored in a memory of a storage device into buckets, wherein a first bucket of the buckets comprises data items that share a first common characteristic. The bucketization logic is to send data items of the first bucket to the host processor for processing by the host processor using a first code module configured for the first common characteristic of the first bucket.
    Type: Application
    Filed: January 18, 2019
    Publication date: July 23, 2020
    Inventors: Martin Ichilevici de Oliveira, Man Pok Ho, Jose Nelson Amaral, Kai-Ting Amy Wang, Yaoqing Gao, Bryan Chan
  • Publication number: 20200108075
    Abstract: 3-Carbonylamino-8-aminoisoquinoline compounds of formula (I): variations thereof, and their use as inhibitors of HPK1 (hematopoietic kinase 1) are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the 3-carbonylamino-8-aminoisoquinoline compounds.
    Type: Application
    Filed: October 3, 2019
    Publication date: April 9, 2020
    Applicant: Genentech, Inc.
    Inventors: Jun LIANG, Rohan V. MENDONCA, Michael SIU, John TELLIS, Weiru WANG, BinQing WEI, Bryan CHAN, Edna F. CHOO, Joy DROBNICK, Lewis J. GAZZARD, Timothy HEFFRON
  • Publication number: 20200000780
    Abstract: Azaindole compounds and their use as inhibitors of HPK1 are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the azaindole compounds.
    Type: Application
    Filed: September 12, 2019
    Publication date: January 2, 2020
    Applicant: Genentech, Inc.
    Inventors: Timothy HEFFRON, Sushant MALHOTRA, BinQing WEI, Bryan CHAN, Lewis GAZZARD, Emanuela GANCIA, Michael LAINCHBURY, Andrew MADIN, Eileen SEWARD, Yonghan HU
  • Patent number: 10407424
    Abstract: Naphthyridine compounds and their use as inhibitors of HPK1 are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the naphthyridine compounds.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: September 10, 2019
    Assignee: Genentech, Inc.
    Inventors: Bryan Chan, Naomi Rajapaksa, Michael Siu, Craig Stivala, John Tellis, Weiru Wang, BinQing Wei, Aihe Zhou, Matthew W. Cartwright, Emanuela Gancia, Graham Jones, Blake Daniels, Michael Lainchbury, Andrew Madin, Eileen Seward, David Favor, Kin Chiu Fong, Andrew Good, Yonghan Hu, Baihua Hu, Aijun Lu, Joy Drobnick, Lewis Gazzard, Timothy Heffron, Malcolm Huestis, Jun Liang, Sushant Malhotra, Rohan Mendonca
  • Patent number: 10282736
    Abstract: Methods and systems for changing a parameter associated with an image displayed on a display screen based on criteria related to a user are described. One of the methods includes receiving a selection of an image from a plurality of images. The method further includes examining the selected image to identify a keyword and criteria associated with the selected image. The keyword includes an identification of the image and the criteria including a time associated with the selected image. The method further includes ranking the selected image compared to remaining images of the plurality of images based on the keyword and the criteria, assigning a weight to an image parameter of the selected image to associate the image parameter with the rank of the selected image, and sending the assigned weight of the image parameter to a display device for display of the selected image according to the assigned weight.
    Type: Grant
    Filed: May 21, 2013
    Date of Patent: May 7, 2019
    Assignee: Excalibur IP, LLC
    Inventors: Grace Tsai, Hsin-Chan Chien, Anne Yu, Fa-Hsien Li, Bryan Chan
  • Publication number: 20180282328
    Abstract: Naphthyridine compounds and their use as inhibitors of HPK1 are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the naphthyridine compounds.
    Type: Application
    Filed: March 30, 2018
    Publication date: October 4, 2018
    Applicant: Genentech, Inc.
    Inventors: Bryan Chan, Blake Daniels, Joy Drobnick, Lewis Gazzard, Timothy Heffron, Malcolm Huestis, Jun Liang, Sushant Malhotra, Rohan Mendonca, Naomi Rajapaksa, Michael Siu, Craig Stivala, John Tellis, Weiru Wang, BinQing Wei, Aihe Zhou, Matthew W. Cartwright, Emanuela Gancia, Graham Jones, Michael Lainchbury, Andrew Madin, Eileen Seward, David Favor, Kin Chiu Fong, Andrew Good, Yonghan Hu, Baihua Hu, Aijun Lu